TNMG News & Events

TNL Mediagene files to sell 1.6M ordinary shares for holders

TNL Mediagene outlined its goal to reach EBITDA break-even in FY26 and positive EBITDA in FY27. For FY, the Company expects to report approximately $49.1M in revenue and $17.8M in gross profit. Management aims to reach EBITDA break-even in FY26, driven by growth in technology business revenue and continued reductions in operating costs through organizational simplification and increased use of automation. Management further aims to achieve positive EBITDA in FY27 through organic growth of its core businesses, development of new products, and disciplined strategic acquisitions.

TNL Mediagene received a letter from the Nasdaq Stock Market on January 20, that the Company has regained compliance with Listing Rule 5550(a)(2), as required by the Nasdaq Hearings Panel's decision dated December 19. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's Ordinary Shares has been at $1.00 per share or greater for fifteen consecutive trading days from December 23, to January 14, 2026. Accordingly, the Company has regained compliance with the Bid Price Rule. The Panel also has determined to impose a Discretionary Panel Monitor under Listing Rule 5815(d)(4)(A) for a period of one year from the date of this letter, to make sure that the Company proactively addresses any future potential compliance concerns and demonstrates long-term compliance with Nasdaq's continued listing requirements.